September 02, 2022
A torrid 2022 for health care litigation is entering a red-hot homestretch featuring fallout from the U.S. Supreme Court's explosive repudiation of abortion rights, the potential for three False Claims Act clashes at the high court, and the increasingly likely prospect of a funding fiasco for the U.S. Food and Drug Administration.
July 21, 2022
A spree of remarkable rulings has already made 2022 a jaw-dropping year for health care and pharmaceutical law, where the U.S. Supreme Court reshaped abortion rights, opioid crisis prosecutions, Medicare's rulemaking powers and vital sources of hospital income. At the midyear mark, Law360 recaps the rulings and analyzes their implications.
June 24, 2022
The U.S. Supreme Court on Friday sided with the U.S. Department of Health and Human Services in a complex battle over special payments for hospitals in low-income areas, capping off a case that left the justices openly bewildered.
June 16, 2022
The U.S. Supreme Court's landmark doctrine requiring judicial deference to federal regulators survived a major health care case at the high court Wednesday, but the controversial bedrock of administrative law barely escaped the conservative justices' frying pan and is heading right back into their fire, experts say.
January 03, 2022
Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.
November 29, 2021
The U.S. Supreme Court on Monday struggled to solve a notorious mathematical muddle involving Medicare reimbursement for hospitals serving lower-income Americans, with several justices expressing bewilderment over legislative text that has spawned decades of litigation.
September 20, 2021
The U.S. Supreme Court on Monday scheduled oral arguments for late November and early December in three high-profile health care cases, including an abortion case that could result in Roe v. Wade being overturned and two appeals over federal limitations on hospital reimbursements.
July 02, 2021
The U.S. Supreme Court on Friday agreed to review whether the federal government lawfully cut billions of dollars from reimbursements for drugs bought through a discount program for hospitals in low-income areas, as well as a reimbursement calculation for hospitals that serve a high amount of low-income individuals.
March 24, 2021
The U.S. Department of Health and Human Services wants the U.S. Supreme Court to look at the Ninth Circuit's undoing of a rule relating to a reimbursement calculation for hospitals that serve a high amount of low-income individuals.